A drug-eluting resorbable stent was found to be just as effective in treating infrapopliteal artery disease in patients at risk of limb amputation, according to a study published Oct. 25 in the New England Journal of Medicine.
Cardiology
Semaglutide treatment was found to reduce healthcare costs significantly for patients with overweight or obesity and who had either heart failure or atherosclerotic cardiovascular disease, according to studies presented Nov. 3-6 at the Obesity Society's annual Obesity Week conference and…
Researchers are starting to learn more about a rare but deadly side effect of immunotherapy cancer treatment, according to a study published Nov. 6 in Nature.
Breast arterial calcifications are benign calcium buildups that in mammograms look like white parallel lines. Measuring these calcifications may improve cardiovascular risk in women, according to a study published Sept. 27 in JACC: Advances.
The American Heart Association will recognize eight leaders in cardiology at the organization's annual Scientific Sessions conference, set for Nov. 16-18.
Sociocultural pressures of masculinity may influence whether men seek out cardiac care, according to a study published Oct. 25 in JAMA Network Open.
California and Florida have the most top-ranked hospitals for pacemaker or defibrillator placement in the U.S., according to the WebMD Choice Awards.
The BiVACOR Total Artificial Heart is included on the "The Best Inventions of 2024" list published Oct. 30 in Time.
CMS has proposed coverage of implantable pulmonary artery pressure sensors for the management of heart failure.
Traditionally, patients with a failing heart valve were advised to return in six to 12 months, as physicians generally took a "wait and see" approach, but a new study suggests patients may benefit more if their valves are replaced immediately…